299 related articles for article (PubMed ID: 30837499)
1. A permeability-increasing drug synergizes with bacterial efflux pump inhibitors and restores susceptibility to antibiotics in multi-drug resistant Pseudomonas aeruginosa strains.
Ferrer-Espada R; Shahrour H; Pitts B; Stewart PS; Sánchez-Gómez S; Martínez-de-Tejada G
Sci Rep; 2019 Mar; 9(1):3452. PubMed ID: 30837499
[TBL] [Abstract][Full Text] [Related]
2. Permeability enhancers sensitize β-lactamase-expressing Enterobacteriaceae and Pseudomonas aeruginosa to β-lactamase inhibitors, thereby restoring their β-lactam susceptibility.
Ferrer-Espada R; Sánchez-Gómez S; Pitts B; Stewart PS; Martínez-de-Tejada G
Int J Antimicrob Agents; 2020 Jul; 56(1):105986. PubMed ID: 32335279
[TBL] [Abstract][Full Text] [Related]
3. Expression of efflux pump MexAB-OprM and OprD of Pseudomonas aeruginosa strains isolated from clinical samples using qRT-PCR.
Arabestani MR; Rajabpour M; Yousefi Mashouf R; Alikhani MY; Mousavi SM
Arch Iran Med; 2015 Feb; 18(2):102-8. PubMed ID: 25644798
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa.
Pan YP; Xu YH; Wang ZX; Fang YP; Shen JL
Arch Microbiol; 2016 Aug; 198(6):565-71. PubMed ID: 27060003
[TBL] [Abstract][Full Text] [Related]
5. An efflux pump (MexAB-OprM) of Pseudomonas aeruginosa is associated with antibacterial activity of Epigallocatechin-3-gallate (EGCG).
Kanagaratnam R; Sheikh R; Alharbi F; Kwon DH
Phytomedicine; 2017 Dec; 36():194-200. PubMed ID: 29157815
[TBL] [Abstract][Full Text] [Related]
6. Conessine as a novel inhibitor of multidrug efflux pump systems in Pseudomonas aeruginosa.
Siriyong T; Srimanote P; Chusri S; Yingyongnarongkul BE; Suaisom C; Tipmanee V; Voravuthikunchai SP
BMC Complement Altern Med; 2017 Aug; 17(1):405. PubMed ID: 28806947
[TBL] [Abstract][Full Text] [Related]
7. Macrolide antibiotic-mediated downregulation of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa.
Sugimura M; Maseda H; Hanaki H; Nakae T
Antimicrob Agents Chemother; 2008 Nov; 52(11):4141-4. PubMed ID: 18676884
[TBL] [Abstract][Full Text] [Related]
8. Fuzheng Touxie Jiedu Huayu Decoction inhibits the MexAB-OprM efflux pump and quorum sensing-mediated biofilm formation in difficult-to-treat multidrug resistance Pseudomonas aeruginosa.
Liu T; Xu H; Huang T; Liu G; Cao H; Lin Y; Li Y; Li Y; Yao X
J Ethnopharmacol; 2024 Oct; 332():118365. PubMed ID: 38796070
[TBL] [Abstract][Full Text] [Related]
9.
Abdelmalek S; Hajar M; Salah L; Abdel-Halim H
Microb Drug Resist; 2024 Feb; 30(2):73-81. PubMed ID: 38150012
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Compensation of Fitness Costs Is a General Outcome for Antibiotic-Resistant
Olivares Pacheco J; Alvarez-Ortega C; Alcalde Rico M; Martínez JL
mBio; 2017 Jul; 8(4):. PubMed ID: 28743808
[TBL] [Abstract][Full Text] [Related]
11. Enhanced efficacy of putative efflux pump inhibitor/antibiotic combination treatments versus MDR strains of Pseudomonas aeruginosa in a Galleria mellonella in vivo infection model.
Adamson DH; Krikstopaityte V; Coote PJ
J Antimicrob Chemother; 2015 Aug; 70(8):2271-8. PubMed ID: 25921513
[TBL] [Abstract][Full Text] [Related]
12. Efflux pump inhibitors reduce the invasiveness of Pseudomonas aeruginosa.
Hirakata Y; Kondo A; Hoshino K; Yano H; Arai K; Hirotani A; Kunishima H; Yamamoto N; Hatta M; Kitagawa M; Kohno S; Kaku M
Int J Antimicrob Agents; 2009 Oct; 34(4):343-6. PubMed ID: 19615866
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of efflux pump inhibitors of MexAB- or MexXY-OprM in Pseudomonas aeruginosa using nucleic acid dyes.
Fujiwara M; Yamasaki S; Morita Y; Nishino K
J Infect Chemother; 2022 May; 28(5):595-601. PubMed ID: 35168878
[TBL] [Abstract][<
